A simple probe measures the pharmacokinetics of [125I]RTI-55 in mouse brain in vivo

European Journal of Pharmacology

Volumn 338, Issue 1, 1997, Pages 17-23

  Mochizuki, Takao ^a   Villemagne, Victor L ^a   Scheffel, Ursula ^a   Xiang Liu, ^a   Musachio, John L ^a   Dannals, Robert F ^a   Wagner Jr , Henry N ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

5 HT (5 hydroxytryptamine, serotonin) transporter; Dopamine transporter; GBR 12909; Paroxetine; RTI 55; Single photon detection system

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; COCAINE; COCAINE DERIVATIVE; DOPAMINE; DOPAMINE TRANSPORTER; PAROXETINE; RADIOLIGAND; SEROTONIN; TRACER; VANOXERINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DRUG RECEPTOR BINDING; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PHOTON; PRIORITY JOURNAL; RADIATION DETECTOR; RADIOACTIVITY;

ABSORPTIOMETRY, PHOTON; ANIMALS; BRAIN; COCAINE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; IODINE RADIOISOTOPES; MALE; MICE; PAROXETINE; PIPERAZINES; RADIOMETRY; SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 0030662719     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01307-1     Document Type: Article

References (32)

1. Andersen P.H. The dopamine uptake inhibitor GBR 12909: Selectivity and molecular mechanism of action. Eur. J. Pharmacol. 166:1989;493-504.
2. Bice A.N., Wagner H.N. Jr., Frost J.J., Natarajan T.K., Lee M.C., Wong D.F., Dannals R.F., Ravert H.T., Wilson A.A., Links J.M. Simplified detection system for neuroreceptor studies in the human brain. J. Nucl. Med. 27:1986;184-191.
3. Boja J.W., Carroll F.I., Rahman M.A., Philip A., Lewin A.H., Kuhar M.J. New, potent cocaine analogs: Ligand binding and transport studies in rat striatum. Eur. J. Pharmacol. 184:1990;329-332.
4. 125I ]RTI-55: A potent ligand for dopamine transporters Eur. J. Pharmacol. 194:1991;133-134.
5. Boja J.W., Cline E.J., Carroll F.I., Lewin A.H., Philip A., Dannals R., Wong D., Scheffel U., Kuhar M.J. High potency cocaine analogs: Neurochemical, imaging and behavioral studies. Ann. N.Y. Acad. Sci. 654:1992;282-291.
6. 125I ]RTI-55 to dopamine and serotonin transporters in rat brain Synapse. 12:1992;27-36.
7. 123I ]3-b-(4-iodophenyl)tropan-2b-carboxylic acid methyl ester (RTI-55) a unique cocaine receptor ligand for imaging the dopamine and serotonin transporters in vivo Med. Chem. Res. 1:1991;289-294.
8. Carroll F.I., Scheffel U., Dannals R.F., Boja J.W., Kuhar M.J. Development of imaging agents for the dopamine transporter. Med. Res. Rev. 15:1995;419-444.
9. 125I ]RTI-55 to dopamine transporters: Pharmacology and regional distribution with autoradiography Synapse. 12:1992;37-46.
10. Elmer G.I., Brockington A., Gorelick D.A., Carrol F.I., Rice K.C., Matecka D., Goldberg S.R., Rothman R.B. Cocaine cross-sensitization to dopamine uptake inhibitors: Unique effects of GBR 12909. Pharmacol. Biochem. Behav. 53:1996;911-918.
11. Heikkila R.E., Manzino L. noL Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: Specific inhibitors of dopamine uptake. Eur. J. Pharmacol. 103:1984;241-248.
12. Izenwasser S., Terry P., Heller B., Witkin J.M., Katz J.L. Differential relationships among dopamine transporter affinities and stimulant potencies of various uptake inhibitors. Eur. J. Pharmacol. 263:1994;277-283.
13. Jeffries, K.J., Kim, S., Wagner, H.N., Jr., 1995. In vivo probes: Pharmacological studies, In: Wagner, H.N., Jr., Szabo, Z., Buchanan, J.W. (Eds.), Principles of Nuclear Medicine, 2nd ed. W.B. Saunders company, Philadelphia, PA, pp. 275-285.
14. Kim, S., Wagner, H.N. Jr., Villemagne, V.L., Kao, P., Dannals, R.F., Ravert, H.T., Joh, T., Dixon, R.B. Civelek, A.C., 1997. Longer occupancy of opioid receptors by nalmefene compared to naloxone as measured in vivo by a dual detector system. J. Nucl. Med., in press.
15. Laruelle M., Baldwin R.M., Innis R.B. SPECT imaging of dopamine and serotonin transporters in nonhuman primate brain. Nida Res. Monogr. 138:1994;131-159.
16. Lee M.C., Wagner H.N. Jr., Tanada S., Frost J.J., Bice A.N., Dannals R.F. Duration of occupancy of opiate receptors by naltrexone. J. Nucl. Med. 29:1988;1207-1211.
17. Liu, X., Musachio, J.L., Wagner, H.N., Jr., Mochizuki, T., Dannals, R.F. London, E.D., 1997. External monitoring of cerebral nicotinic acetylcholine receptors in living mice. Synapse, in press.
18. Melia K.F., Spealman R.D. nR. Pharmacological characterization of the discriminative-stimulus effects of GBR 12909. J. Pharmacol. Exp. Ther. 258:1991;626-632.
19. Montemurro, D.G., Dukelow, R.H., 1972. A Stereotaxic Atlas of the Diencephalon and Related Structures of the Mouse. Futura publishing company, Mount Kisco, New York.
20. Nakahara D., Hashiguti H., Kaneda N., Sasaoka T., Nagatsu T. Normalization of tyrosine hydroxylase activity in vivo in the striatum of transgenic mice carrying human tyrosine hydroxylase gene: A microdialysis study. Neurosci. Lett. 158:1993;44-46.
21. 3H ]WIN 35,428 binding to dopamine uptake sites in vivo more rapidly than mazindol or GBR 12909 Eur. J. Pharmacol. 198:1991;203-205.
22. Rothman R.B., Xu H., Seggel M., Jacobson A.E., Rice K.C., Brine G.A., Carroll F.I. RTI-4614-4: An analog of (+)-cis-3-methylfentanyl with a 27,000-fold binding selectivity for mu versus delta opioid binding sites. Life Sci. 48:1991;111-116.
23. Rothman R.B., Xu H., Wang J.B., Partilla J.S., Kayakiri H., Rice K.C., Uhl G.R. Ligand selectivity of cloned human and rat opioid mu receptors. Synapse. 21:1995;60-64.
24. 125I ]-4-iodolevetimide Neuropharmacology. 32:1993;1441-1443.
25. 3H ]paroxetine J. Neurochem. 52:1989;1605-1612.
26. 3H ]WIN 35,428 J. Pharmacol. Exp. Ther. 257:1991;954-958.
27. 125I ]RTI-55, an in vivo label for the serotonin transporter Synapse. 11:1992;134-139.
28. 125I ]RTI-55 Synapse. 16:1994;263-268.
29. Shaya E.K., Scheffel U., Dannals R.F., Ricaurte G.A., Carroll F.I., Wagner H. Jr., Kuhar M.J., Wong D.F. In vivo imaging of dopamine reuptake sites in the primate brain using single photon emission computed tomography (SPECT) and iodine-123 labeled RTI-55. Synapse. 10:1992;169-172.
30. van der Zee P., Koger H.S., Gootjes J., Hespe W. Aryl 1,4-dialk(en)ylpiperazines as selective and very potent inhibitors of dopamine uptake. Eur. J. Med. Chem. 15:1980;363-370.
31. 11C ]carfentanil in vivo binding to opiate receptors in man using a dual detector system Eur. J. Pharmacol. 257:1994;195-197.
32. Westerink B.H., Damsma G., De V.J., Koning H. Dopamine re-uptake inhibitors show inconsistent effects on the in vivo release of dopamine as measured by intracerebral dialysis in the rat. Eur. J. Pharmacol. 135:1987;123-128.